These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

301 related items for PubMed ID: 8171460

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Splenectomy is a potent immunosuppressive modality for cardiac xenografting.
    Carobbi A, Araneda D, Thomas F, Quarantillo P, Thomas J.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):419-20. PubMed ID: 8438360
    [No Abstract] [Full Text] [Related]

  • 3. Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation.
    Xiao F, Shen J, Chong A, Liu W, Foster P, Blinder HL, Sankary H, McChesney L, Mital D, Williams JW.
    Transplant Proc; 1996 Apr; 28(2):691-2. PubMed ID: 8623348
    [No Abstract] [Full Text] [Related]

  • 4. Effect of leflunomide, cyclosporine, and splenectomy in two different organ systems of concordant xenotransplantation in rats.
    Salomon S, Steinbrüchel DA, Nielsen B, Lillevang S, Kemp E.
    Transplant Proc; 1996 Apr; 28(2):698-9. PubMed ID: 8623352
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Induction therapy of leflunomide and cyclosporine allows for long-term xenograft survival under cyclosporine alone.
    Lin Y, Sobis H, Vandeputte M, Waer M.
    Transplant Proc; 1994 Oct; 26(5):3052. PubMed ID: 7940959
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine.
    Chong AS, Shen J, Xiao F, Blinder L, Foster P, Sankary H, Williams JW.
    Transplant Proc; 1996 Apr; 28(2):684. PubMed ID: 8623344
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Delayed cardiac xenograft rejection in a pig-to-baboon model treated with a tolerance-inducing regimen and donor bone marrow infusion.
    Xu H, Gundry SR, Hancock W, Matsumiya G, Bailey LL.
    Transplant Proc; 2000 Aug; 32(5):1084-5. PubMed ID: 10936368
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Tetrahydropyranyladriamycin with FK 506 combination therapy for hamster-to-rat-concordant xenotransplantation.
    Namii Y, Yasutomi M, Hayashi S, Ito M, Ohtsuka S, Uchida K, Yokoyama I, Takagi H.
    Transplant Proc; 1996 Apr; 28(2):709-10. PubMed ID: 8623358
    [No Abstract] [Full Text] [Related]

  • 16. Prolongation of xenograft survival by exchange transfusions and immunosuppression.
    Bouwman E, de Bruin RW, Jeekel J, Marquet RL.
    Transplant Proc; 1990 Jun; 22(3):1079-80. PubMed ID: 2190374
    [No Abstract] [Full Text] [Related]

  • 17. Synergistic effect of donor pretreatment using FK 506 in hamster-to-rat cardiac xenotransplantation.
    Hayashi S, Ito M, Yokoyama I, Uchida K, Takagi H.
    Transplant Proc; 1994 Jun; 26(3):1284. PubMed ID: 7518126
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of leflunomide and cyclosporine on the occurrence of chronic xenograft lesions.
    Lin Y, Vandeputte M, Waer M.
    Kidney Int Suppl; 1995 Dec; 52():S23-8. PubMed ID: 8587278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.